“I am excited to join AVAVA’s Board of Directors and work with a team committed to advancing the next generation of ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a regional leader in advanced ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to ...

The new South Sioux City Autism Center is set to serve up to 25 families in the local community and will create 35 new job opportunities. This development reflects our ongoing commitment to providing ...

Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer. In this role, Dr. Berberian ...

March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the U.S. Food and Drug ...

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today ...

CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of Jerome ...

Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced the acquisition of BenefitBump, a comprehensive parental leave benefits ...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information About Mainz Biomed NV Mainz Biomed develops market-ready molecular genetic diagnostic ...